Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FONDAPARINUX for Pulmonary embolism: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 115 adverse event reports in the FDA FAERS database where FONDAPARINUX was used for Pulmonary embolism.

Most Reported Side Effects for FONDAPARINUX

Side Effect Reports % Deaths Hosp.
Off label use 356 16.0% 36 195
Haematoma 168 7.5% 21 137
Anaemia 159 7.1% 19 124
Drug ineffective 117 5.3% 15 60
Pulmonary embolism 97 4.4% 11 50
Haemorrhage 89 4.0% 25 36
Cerebral haemorrhage 78 3.5% 38 43
Heparin-induced thrombocytopenia 76 3.4% 8 36
Thrombocytopenia 72 3.2% 11 32
Thrombosis 71 3.2% 7 27
Shock haemorrhagic 67 3.0% 19 41
Pruritus 61 2.7% 1 42
Deep vein thrombosis 56 2.5% 5 20
Dyspnoea 54 2.4% 8 37
Melaena 53 2.4% 4 46

Other Indications for FONDAPARINUX

Product used for unknown indication (453) Thrombosis prophylaxis (348) Deep vein thrombosis (166) Anticoagulant therapy (155) Atrial fibrillation (78) Thrombosis (71) Acute coronary syndrome (63) Off label use (57) Acute myocardial infarction (54) Prophylaxis (54)

Other Drugs Used for Pulmonary embolism

RIVAROXABAN (11,707) APIXABAN (5,234) WARFARIN (1,552) ENOXAPARIN (1,155) HEPARIN (786) ALTEPLASE (617) DABIGATRAN ETEXILATE (527) DALTEPARIN (431) EDOXABAN (307) XARELTO (284)

Related Pages

FONDAPARINUX Full Profile All Pulmonary embolism Drugs FONDAPARINUX Demographics FONDAPARINUX Timeline